Medical News

RSS

Previous SARS-CoV-2 infection may negate need for two vaccine doses

Researchers in the United States have shown that two doses of vaccine may not be necessary to protect against coronavirus disease 2019 (COVID-19) among people who have already been infected with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 Feb 2021

MIT engineers design origami-inspired medical patch for minimally invasive tissue sealing

Many surgeries today are performed via minimally invasive procedures, in which a small incision is made and miniature cameras and surgical tools are threaded through the body to remove tumors and repair damaged tissues and organs.

2 Feb 2021

Regenstrief and Boomerang Ventures partner to expand the reach of healthcare innovations

Regenstrief Institute and Boomerang Ventures are announcing a partnership to develop and disseminate healthcare solutions to improve the well-being of people around the world.

2 Feb 2021

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Chimeric antigen receptor T-cell therapy, or CAR T, has been a breakthrough in the treatment of blood cancers such as acute lymphoblastic leukemia and diffuse large B-cell lymphoma.

2 Feb 2021

Decision-support tool may help clinicians to appropriately treat children with diarrhea

A decision-support tool that could be accessed via mobile devices may help clinicians in lower-resource settings avoid unnecessary antibiotic prescriptions for children with diarrhea, a study published today in eLife shows.

2 Feb 2021

Kids with autism show the biggest drop in physical activity between ages 9 to 13

A recent study from Oregon State University has found that to best help kids with autism maintain healthy rates of physical activity, interventions should be targeted during the ages of 9 to 13, as that's when kids show the biggest drop in active time.

2 Feb 2021

Study finds increased opioid consumption two years after intensive care

Nearly 11 percent of people admitted to an intensive care unit in Sweden between 2010 and 2018 received opioid prescriptions on a regular basis for at least six months and up to two years after discharge.

2 Feb 2021

New guidance to provide mental health support for people with neurodegenerative conditions

Lancaster University together with the British Psychological Society has provided research-based recommendations for mental health support for people living with four motor neurodegenerative conditions.

2 Feb 2021

Study identifies triggers for acute decompensation of liver cirrhosis

Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.

2 Feb 2021

Simple soil remediation can save children from lead toxicity

Simple soil remediation can substantially reduce levels of the toxic metal lead in the blood of children living in heavily contaminated areas, says a new study conducted in Bangladesh.

2 Feb 2021

Study examines the link between walnut metabolites and risk of cardiometabolic diseases

Researchers, from the Harvard T.H. Chan School of Public Health in collaboration with investigators from Rovira i Virgili University and the University of Navarra, Spain, used machine learning models, a subset of artificial intelligence, to identify more precisely the components in walnuts that may be responsible for potentially reducing the risk of type 2 diabetes and cardiovascular diseases - two of the leading causes of death in the U.S.

2 Feb 2021

Study shows link between periodontitis and COVID-19 complications

COVID-19 patients are at least three times more likely to experience complications if they also have gum disease, according to research published today in the Journal of Clinical Periodontology, the official publication of the European Federation of Periodontology.

2 Feb 2021

Delaying colonoscopy after an abnormal stool test can have major consequences

A new Veterans Affairs study finds that delays in undergoing colonoscopy following an abnormal stool test increase the risk of a colorectal cancer diagnosis and cancer-related death.

2 Feb 2021

Study shows safety and effectiveness of two recommended ICU sedatives

Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia.

2 Feb 2021

MCRI specialists create Australia's and New Zealand's first set of child head injury guidelines

Australia's and New Zealand's first set of clinical guidelines for children's head injuries has been created by a network of specialists based at the Murdoch Children's Research Institute.

2 Feb 2021

What is the structure and function of SARS-CoV-2’s D614G spike mutation?

A team of researchers use a computational approach to integrate available data D614G SARS-CoV-2 spike mutation, exploring its structure and molecular mechanisms.

2 Feb 2021

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

A new preprint reports the efficacy of two repurposed drugs that could be useful against SARS-CoV-2 when supplemented with zinc.

2 Feb 2021

Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 variants

A team of researchers in the U.S. studied the Pfizer-BioNTech vaccine candidate - currently being rolled out in many parts of the world to high-risk individuals - to see if it still holds up against mutant strains of the virus and yielded encouraging results.

2 Feb 2021

ACE2 agonist C21 relieves respiratory difficulty in COVID-19

A new study describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting enzyme 2 (ACE2), the host cell receptor that facilitates viral entry.

2 Feb 2021

Antiviral compound GC-376 shows efficacy against SARS-CoV-2 in vivo

Over the past months, many potential antivirals against SARS-CoV-2 have been identified as deserving further development to target several viral proteins. A new study deals with one such molecule, the viral main protease (Mpro) inhibitor GC-376, and describes its efficacy in inhibiting virus-host interaction.

2 Feb 2021

Medical News

Previous SARS-CoV-2 infection may negate need for two vaccine doses

MIT engineers design origami-inspired medical patch for minimally invasive tissue sealing

Regenstrief and Boomerang Ventures partner to expand the reach of healthcare innovations

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Decision-support tool may help clinicians to appropriately treat children with diarrhea

Kids with autism show the biggest drop in physical activity between ages 9 to 13

Study finds increased opioid consumption two years after intensive care

New guidance to provide mental health support for people with neurodegenerative conditions

Study identifies triggers for acute decompensation of liver cirrhosis

Simple soil remediation can save children from lead toxicity

Study examines the link between walnut metabolites and risk of cardiometabolic diseases

Study shows link between periodontitis and COVID-19 complications

Delaying colonoscopy after an abnormal stool test can have major consequences

Study shows safety and effectiveness of two recommended ICU sedatives

MCRI specialists create Australia's and New Zealand's first set of child head injury guidelines

What is the structure and function of SARS-CoV-2’s D614G spike mutation?

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 variants

ACE2 agonist C21 relieves respiratory difficulty in COVID-19

Antiviral compound GC-376 shows efficacy against SARS-CoV-2 in vivo

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News